Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis
Article in Biomedicine & Pharmacotherapy (October 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Biomedicine & Pharmacotherapy (October 2023)